Intrinsic Value of S&P & Nasdaq Contact Us

Glaukos Corporation GKOS NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$143.44
+19%

Stock Statistics — GKOS

Glaukos Corporation (GKOS) has a market capitalization of $7B and trades at $120.52. The 52-week range is 73.16-130.23.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -36.7, Earnings Per Share (EPS) of $-3.28, annual revenue of $507.44M.

The stock has a beta of 0.78, operates in the Healthcare sector.

Trading Data
Current Price$120.52
52-Week Range73.16-130.23
Volume562.15K
Avg Volume (30D)795.35K
Market Cap$7B
Beta (1Y)0.78
Company
IPO Date2015-06-25
Employees995
CEOThomas William Burns
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS3773221029
CUSIP377322102
Income (Latest Year)
Revenue$507.44M
Gross Profit$282.76M
EBITDA$-150.31M
Operating Income$-199.6M
Net Income$-187.69M
EPS$-3.28
EPS Diluted$-3.28
Shares Outstanding$57.19M
Balance Sheet (Latest Year)
Total Assets$893.49M
Current Assets$474.98M
Cash & ST Investments$278.76M
Total Liabilities$237.33M
Total Debt$139.64M
Net Debt$48.83M
Total Equity$656.16M
Debt / Equity0.21
Valuation Ratios
P/E Ratio-36.7
P/S Ratio13.79
P/B Ratio10.67
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message